MRGPRX2 Activation Causes Increased Skin Reactivity in Patients with Chronic Spontaneous Urticaria

J Invest Dermatol. 2021 Mar;141(3):678-681.e2. doi: 10.1016/j.jid.2020.06.030. Epub 2020 Aug 7.
No abstract available

Publication types

  • Letter
  • Observational Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Atracurium / administration & dosage*
  • Bradykinin / administration & dosage
  • Bradykinin / analogs & derivatives*
  • Case-Control Studies
  • Cell Line
  • Chronic Urticaria / diagnosis*
  • Chronic Urticaria / immunology
  • Female
  • Gene Knockout Techniques
  • Healthy Volunteers
  • Humans
  • Injections, Subcutaneous
  • Male
  • Middle Aged
  • Nerve Tissue Proteins / agonists
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism*
  • Receptors, G-Protein-Coupled / agonists
  • Receptors, G-Protein-Coupled / genetics
  • Receptors, G-Protein-Coupled / metabolism*
  • Receptors, Neuropeptide / agonists
  • Receptors, Neuropeptide / genetics
  • Receptors, Neuropeptide / metabolism*
  • Skin / drug effects
  • Skin / immunology
  • Skin Tests / methods
  • Young Adult

Substances

  • MRGPRX2 protein, human
  • Nerve Tissue Proteins
  • Receptors, G-Protein-Coupled
  • Receptors, Neuropeptide
  • Atracurium
  • icatibant
  • Bradykinin